Biogen Earnings, Revenue beat In Q3

  • Investing.com
  • Stock Market News
Biogen Earnings, Revenue beat In Q3
Credit: © Reuters.

Investing.com - Biogen (NASDAQ: BIIB ) reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Biogen announced earnings per share of $4.77 on revenue of $2.78B. Analysts polled by Investing.com anticipated EPS of $4.12 on revenue of $2.67B.

Biogen shares are up 9% from the beginning of the year and are trading at $268.13 , down-from-52-week-high.They are under-performing the Nasdaq 100 which is up 19.57% from the start of the year.

Biogen follows other major Healthcare sector earnings this month

Biogen's report follows an earnings beat by J&J on Tuesday, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.36 on revenue of $23.66B.

Intuitive Surgical had beat expectations on Tuesday with third quarter EPS of $1.19 on revenue of $1.4B, compared to forecast for EPS of $1.17 on revenue of $1.39B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100